Skip to main content

Markers of Depression

Researchers have identified biomarkers that could help diagnose and treat major depression from a blood test, the Economist reports.

Currently, major depression is diagnosed by physicians' assessment of patients' mood, an approach that the Economist notes can be subjective. In the journal Molecular Psychiatry last month, researchers led by Indiana University School of Medicine's Alexander Niculescu analyzed blood samples from an initial cohort of 44 people with a mood disorder to identify genes whose expression changed with differences in patients' symptoms. After testing these RNA expression markers in additional cohorts, the researchers uncovered a panel of 13 biomarkers that can not only detect depression but also predict who might go on to develop bipolar disorder. The Economist notes that three of the genes in the panel may also give insight into which treatment may be the most appropriate.

As GenomeWeb reports, Niculescu is also a co-founder of MindX Science, which is currently offering RNA expression biomarkers testing for psychiatric conditions as laboratory-developed blood tests and following further validation, plans to seek approval from the US Food and Drug Administration for its tests.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.